Analysis of relapse rates in pegylated interferon and ribavirin non-responders treated with daily consensus interferon and ribavirin

被引：0
|
作者：
Hassanein, Tarek
Ghalib, Reem H.
Zein, Nizar N.
Rothstein, Kenneth D.
Joshi, Shobha N.
Kwo, Paul Yien
Hammond, Janet
机构：
[1] Univ Calif San Diego, Ctr Liver, San Diego, CA 92103 USA
[2] Methodist Hosp, Liver Inst, Dallas, TX USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
[4] Albert Einstein Ctr Liver Dis, Philadelphia, PA USA
[5] Tulane Univ, New Orleans, LA 70118 USA
[6] Indiana Univ, Indianapolis, IN 46204 USA
[7] Valeant Pharmaceut N Amer, Aliso Viejo, CA USA
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1319
引用
收藏
页码：824A / 824A
页数：1
相关论文
共 50 条
  • [31] Consensus interferon in combination with ribavirin for hepatitis C patients with nonresponse or relapse to interferon alpha and ribavirin.
    Buggisch, P
    Hinrichsen, H
    Hueppe, D
    Reiser, M
    Kueppers, H
    Wursthorn, K
    Sterneck, M
    HEPATOLOGY, 2001, 34 (04) : 590A - 590A
  • [32] Consensus interferon and ribavirin in patients with chronic hepatitis C who were nonresponders to prior therapy with either interferon alfa and ribavirin or pegylated interferon and ribavirin
    Chen, K
    Seraphin, P
    Murphy, L
    Shah, N
    HEPATOLOGY, 2005, 42 (04) : 670A - 670A
  • [33] A comparison of combination therapy with interferon and ribavirin vs interferon and amantadine in interferon non-responders with chronic hepatitis C.
    Khalili, M
    Olmeda, M
    Denham, CB
    Perrillo, RP
    HEPATOLOGY, 1998, 28 (04) : 169A - 169A
  • [34] Successful retreatment of interferon/ribavirin nonresponders with daily dosing of consensus interferon
    Kaiser, S
    Hass, HG
    Gregor, M
    JOURNAL OF HEPATOLOGY, 2005, 42 : 207 - 208
  • [35] Impaired sensitivity in non-responders to pegylated interferon plus ribavirin therapy assessed by 2′-5′-oligoadenylate synthetase activity
    Shindo, Michiko
    Hamada, Kazushige
    Morikawa, Teruhisa
    Harano, Yuichi
    Nakajima, Tomoaki
    Okuno, Tadao
    HEPATOLOGY, 2007, 46 (04) : 388A - 388A
  • [36] Anterior uveitis in a patient treated with pegylated interferon and ribavirin
    Martín, JAC
    Coronel, AF
    Delgado, AA
    San Martín, FG
    MEDICINA CLINICA, 2003, 120 (09): : 359 - 359
  • [37] Interferon-alpha plus ribavirin combination therapy for the treatment of chronic hepatitis C in interferon non-responders
    Hasan, F
    Asker, H
    Al Shamali, M
    Al Kalaoui, M
    Al Nakib, B
    HEPATO-GASTROENTEROLOGY, 2000, 47 (36) : 1642 - 1644
  • [38] Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C
    Teuber, G
    Berg, T
    Hoffmann, RM
    Leifeld, L
    Lafrenz, M
    Spengler, U
    Pape, GR
    Hopf, U
    Zeuzem, S
    DIGESTION, 2000, 61 (02) : 90 - 97
  • [39] Interferon alfa plus ribavirin in chronic hepatitis C relapsers and non-responders to previous interferon alfa course
    Salmerón, J
    Vivaldi, RM
    De la Mata, M
    Romero, M
    Moreno, JP
    Aguilar, J
    Palacios, A
    Nogueras, F
    Vignote, M
    Alcántara, R
    Suarez, E
    Andrade, R
    Rodriguez, L
    Sanchez, H
    Quintero, D
    JOURNAL OF HEPATOLOGY, 2000, 32 : 185 - 185
  • [40] Interferon plus ribavirin re-treatment in hemophilic patients relapsers or non-responders to interferon alone.
    Rumi, M
    Santagostino, E
    Soffredini, R
    Rivi, M
    Gringeri, A
    Colombo, M
    Mannucci, PM
    HEPATOLOGY, 2000, 32 (04) : 557A - 557A
12345